[Collaboration & Exchange] Central South University Vice President Li Zhihong Leads Delegation to Shenzhen Cell Valley for Inspection

This morning, Li Zhihong, Vice President of Central South University, led a delegation to visit Shenzhen Cell Valley. The group included Professor Guo Xiaoning from the Second Xiangya Hospital, Office Director Wang Yang, Yang Yifeng, Dean of Shenzhen Pingshan District Central Hospital, Department Director and Researcher Tan Zhiping, and Office Director Shen Yuncheng. They were warmly welcomed by Professor Shi Yuanyuan, Chairman and General Manager of Shenzhen Cell Valley, along with the company’s management team.

Professor Shi Yuanyuan guided the guests through the Smart Exhibition Hall, providing an in-depth overview of the company’s strategic positioning in the Cell and Gene Therapy (CGT) sector, its core technological pathways, and its capabilities in GMP-grade cell product manufacturing. He presented the company’s end-to-end service ecosystem spanning “Research – Clinical – Industry,” which covers the entire value chain from early-stage viral vector construction and stable cell line development to IND-enabling production, process scale-up, quality control, and commercial manufacturing.

During the subsequent symposium, Professor Shi Yuanyuan emphasized that, leveraging its deep technical expertise and innovation in cell therapy, Shenzhen Cell Valley will synergize with the clinical platforms and professional medical teams at Pingshan District Central Hospital to deliver comprehensive support ranging from R&D to clinical application.

Vice President Li Zhihong noted that Central South University had already established an industry-academia-research partnership with Pingshan District Central Hospital in 2024, focusing on collaborative research in oncology, cardiovascular diseases, and metabolic disorders. He stated that this visit aimed to forge a closed-loop collaboration with Shenzhen Cell Valley in areas such as joint quality system development, talent training, and co-application for Investigator-Initiated Trials (IITs). The ultimate goal is to establish a benchmark integrated innovation center anchored at Pingshan Central Hospital, accelerating the translation of scientific breakthroughs and delivering high-standard, internationally aligned precision healthcare to the local community.